Advanced Search


Study ID Status Title Patient Level Data
201111 Relinquished WEUSKOP7136: A global, prospective cohort study to evaluate the real-world use of eltrombopag in adult patients with chronic Hepatitis C Virus infection who are unable to initiate or maintain optimal interferonbased therapy due to thrombocytopenia
201112 Recruiting Occurrence of potential bacterial and viral pathogens in stable chronic obstructive pulmonary disease (COPD) and during acute exacerbations of COPD (AECOPD), in Asia Pacific
201114 Active, Not Recruiting Reasons for discontinuation of injectable diabetes medications: wave 2
201117 Not yet recruiting Evaluation of belimumab use in routine clinical practice: observations in France
201120 Completed A Phase IIa Study to Evaluate the Safety, Tolerability and Acceptability of Long Acting Injections of the HIV Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)
201121 Not yet recruiting Epidemiological study assessing the Burden of Illness related to COPD exacerbations in Québec
201122 Completed Epidemiological study assessing the treatment gaps for COPD patients managed with maintenance bronchodilators in Quebec.
201124 Withdrawn Immunogenicity and safety of GSK Biologicals’ DTPa-IPV/Hib conjugate vaccine (Infanrix™-IPV/Hib) (SB213503) in healthy Indian infants
201128 Terminated A phase II study to evaluate the effects of up to 12 weeks of pazopanib dosing on bleeding in subjects with hereditary haemorrhagic telangiectasia
201131 Completed A randomised, double-blind, study to investigate the effects of creatine supplementation on muscle energetics and cognitive function in young healthy male athletes and an ageing population using phosphorus-31 magnetic resonance spectroscopy (31P MRS) and functional magnetic resonance imaging (fMRI)
201133 Completed A methodology study to evaluate a sitting knee measuring device in assessing growth in Indian children aged 6 to 12 years receiving nutritional supplement with or without micronutrient fortification
201135 Completed 201135 : A Randomised, Double-blind, Multicenter, Parallel-group Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily with Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Subjects Stepped Down from a Maintenance Therapy with RELVAR® inhaler (FF/VI) 100/25 mcg Once-daily in Japanese Subjects Study Listed on
201137 Completed An Evaluation of DCE-MRI measures of Pulmonary Oedema and Vascular Permeability in Healthy Subjects and in Patients with Cardiac Failure: A Methods Validation Study for Evaluation of Novel Treatments Limiting Pulmonary Oedema in Cardiac Failure
201147 Completed 201147: a Phase IIIb, randomized, open-label study of the safety, efficacy, and tolerability of switching to a fixed-dose combination of abacavir/dolutegravir/ lamivudine from current antiretroviral regimen compared with continuation of the current antiretroviral regimen in HIV-1 infected adults who are virologically suppressed, The STRIIVING Study.
201152 Active, Not Recruiting Indirect treatment comparisons of Ph3 combination studies for dabrafenib plus trametinib versus other treatments
201153 Completed Updated analyses adjusting for treatment crossover in Part C of a Phase 2 trial (BRF113220) of dabrafenib and trametinib combination therapy in patients with metastatic melanoma based on recent dataset (March 2013)
201156 Not yet recruiting Prostate Research On Behaviour & Education (PROBE II) Survey. Cross-sectional, multinational, qualitative study to explore and identify patient and healthcare provider attitudes to benign prostatic hyperplasia in Asia Pacific, Latin America, and Commonwealth of Independent States (CIS)
201159 Completed A Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate the Effect of 12 weeks of Once-daily Dosing of the Oral Motilin Receptor Agonist Camicinal, on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects with Gastroparesis
201167 Completed A Phase I, open label, parallel group, three period, fixed sequence crossover study to evaluate the effect of dolutegravir on metformin pharmacokinetics in healthy adult subjects
201182 Completed Meta-Analysis Plan for Study Number 201182, GSK1550188, SLE, Pregnancy Analysis
201186 Completed Utilization of Rosiglitazone in Triple Therapy and Insulin Combinations and Estimated Rates of Adverse Events in Rosiglitazone Recipients in Canada, 2011-2012
201187 Withdrawn A randomized, double-blind, placebo-controlled Phase II study of pazopanib versus placebo as maintenance therapy for patients who have not progressed after first-line chemotherapy for advanced soft tissue sarcoma (STS)
201188 Completed PGx7529: Exploratory Pharmacogenetic evaluation of Potential Modifiers of Duchenne Muscular Dystrophy patient response to Drisapersen
201190 Active, not recruiting Efficacy, safety and immunogenicity of GSK Biologicals’ HZ/su vaccine GSK1437173A in a phase IIIb, open-label, long-term follow-up study (ZOE-LTFU) of studies 110390/113077 (ZOSTER-006/022) and assessment of additional doses in older adults
201191 Active, Not Recruiting A Prospective and Retrospective Observational Study of Real-World Treatment Patterns in Patients with HER2+Advanced or Metastatic Breast Cancer in Europe and the United States



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.